Laurie Stelzer Net Worth & Insider Trades
Laurie Stelzer - SVP, Halozyme Therapeutics, Inc
What is Laurie Stelzer's Net Worth?
The current estimated net worth of Halozyme Therapeutics, Inc's SVP, Laurie Stelzer, is estimated to be about $7.18M . Laurie Stelzer owns about 10,000 units of Halozyme Therapeutics, Inc common stock. In the last 5 years at Halozyme Therapeutics, Inc, Laurie Stelzer has sold an estimated value of $1.13M worth.
What is Laurie Stelzer's Past Insider Trading?
Laurie Stelzer's largest purchase order was 10,000 units , worth over $172.38K on August 24, 2015. In total, Laurie Stelzer has made about 21 transactions over 5 years of their time at Halozyme Therapeutics, Inc. Laurie Stelzer usually trades in February, with the busiest year in 2019 and 2020.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Laurie Stelzer
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Laurie Stelzer's Salary in 2020?
As SVP of Halozyme Therapeutics, Inc, Laurie Stelzer has a total base salary of $93,225 . Laurie Stelzer received compensation valued at about $171,221 in 2020 after becoming SVP. The vast majority of their compensation came in the form of other compensation of $77,996 .
What is Laurie Stelzer's' Mailing Address?
- Mailing address is 6154 Nancy Ridge Drive San Diego CA 92121 CA
Halozyme Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Helen I. Torley | 2020 | $791,440 | - | $2,500,018 | $2,500,001 | $712,270 | $15,147 | $6,518,876 |
| Helen I. Torley | 2019 | $761,000 | - | $2,184,130 | $2,184,128 | $712,296 | $15,572 | $5,857,126 |
| Helen I. Torley | 2018 | $725,000 | - | $2,115,640 | $2,115,631 | $831,665 | $11,733 | $5,799,669 |
| Elaine D. Sun | 2020 | $395,833 | $150,000 | $1,500,269 | $1,000,008 | $180,352 | $133,399 | $3,359,861 |
| Laurie D. Stelzer | 2020 | $93,225 | - | - | - | - | $77,996 | $171,221 |
| Laurie D. Stelzer | 2019 | $495,000 | $2,500 | $750,016 | $750,005 | $231,660 | $16,939 | $2,246,120 |
| Laurie D. Stelzer | 2018 | $470,000 | - | $575,018 | $575,009 | $323,489 | $9,409 | $1,952,925 |
| Masaru Matsuda | 2020 | $440,000 | $50,000 | $500,019 | $500,008 | $203,940 | $13,901 | $1,707,868 |
| Michael J. LaBarre | 2020 | $475,000 | - | $650,009 | $650,007 | $220,163 | $15,018 | $2,010,197 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1159036/000115903621000019/halodefproxy2021.htm
What are Halozyme Therapeutics, Inc's Past Insider Trades?
Halozyme Therapeutics, Inc's most recent insider trade came on September 19, 2023 by Michael Labarre who sold 10,000 units worth $390.98K . In the last 16 years, insiders at Halozyme Therapeutics, Inc have sold an estimated value of $154.9M and bought an estimated value of $85.8M worth of shares. Insider trading is most common in February, with the busiest year in 2007. The most active traders at the company are Helen Torley, PRESIDENT AND CEO, Michael Labarre, SVP, and Gregory Ian Frost, CEO .
HALOZYME THERAPEUTICS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||